help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on September 7, 2006, doi:10.1164/rccm.200603-423OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200603-423OCv1
174/11/1211    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kraemer, R.
Right arrow Articles by Crameri, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kraemer, R.
Right arrow Articles by Crameri, R.
American Journal of Respiratory and Critical Care Medicine Vol 174. pp. 1211-1220, (2006)
© 2006 American Thoracic Society
doi: 10.1164/rccm.200603-423OC


Original Article

Effect of Allergic Bronchopulmonary Aspergillosis on Lung Function in Children with Cystic Fibrosis

Richard Kraemer, Natascha Deloséa, Pietro Ballinari, Sabina Gallati and Reto Crameri

Departments of Paediatrics and Psychiatry, and Division of Human Genetics, University of Bern, Bern; and Swiss Institute of Allergy and Asthma Research, Davos, Switzerland

Correspondence and requests for reprints should be addressed to Richard Kraemer, M.D., Professor and Chairman, Department of Paediatrics, University of Bern, Inselspital, CH-3010 Bern, Switzerland. E-mail: richard.kraemer{at}insel.ch

Rationale: The relationship between sensitization to Aspergillus fumigatus and progression of pulmonary function is not yet established in cystic fibrosis (CF).

Objectives: We aimed to evaluate onset of A. fumigatus sensitization and development of allergic bronchopulmonary aspergillosis (ABPA), as well as to determine the physiologic factors of lung function influencing these mechanisms in CF.

Methods: Serial annual lung function tests performed in 122 children with CF (62 males; 60 females; age: 6–18 yr) provided data pertaining to FRC measured by plethysmography, lung clearance index, volume of trapped gas, effective specific airway resistance, and forced expiratory indices (FEV1, FEF at 50% VC). Specific IgE to recombinant A. fumigatus allergens, rAspf1 and rAspf3, served as marker for sensitization, and to rAspf4 and rAspf6 as indications for a serologic ABPA, were clinically diagnosed (Nelson criteria). By linear mixed-effect model analysis, five patient groups, (1) not sensitized and free from Pseudomonas aeruginosa, (2) intermittently P. aeruginosa colonized, (3) chronically P. aeruginosa infected, (4) sensitized, and (5) with ABPA, were retrospectively evaluated.

Measurements and Main Results: A. fumigatus sensitization was best reflected by increased rAspf1+3-specific IgE levels, whereas, in most patients, sensitization was preceded by P. aeruginosa infection. Patients with ABPA demonstrated the most severe progression in all lung function parameters, and FEF at 50% VC, volume of trapped gas, and effective specific airway resistance were the best predictors (p < 0.0001). However, regarding distinction between sensitization to A. fumigatus and development of ABPA in the course of CF, chronic P. aeruginosa infection has to be taken into account.

Conclusions: Airway narrowing, gas trapping, and small airway disease are the major targets for functional derangement in ABPA.

Key Words: allergic bronchopulmonary aspergillosis • Aspergillus fumigatus sensitization • cystic fibrosis • lung function • Pseudomonas aeruginosa infection


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
The relationship between sensitization to Aspergillus fumigatus and progression of pulmonary function in patients with cystic fibrosis is yet unclear.

What This Study Adds to the Field
We demonstrate how lung function deteriorates over time in relation to A. fumigatus sensitization and allergic bronchopulmonary aspergillosis based on extended pulmonary function characterization.

 



This article has been cited by other articles:


Home page
ChestHome page
R. Agarwal
Allergic Bronchopulmonary Aspergillosis
Chest, March 1, 2009; 135(3): 805 - 826.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. J. Kozlowska, A. Bush, A. Wade, P. Aurora, S. B. Carr, R. A. Castle, A.-F. Hoo, S. Lum, J. Price, S. Ranganathan, et al.
Lung Function from Infancy to the Preschool Years after Clinical Diagnosis of Cystic Fibrosis
Am. J. Respir. Crit. Care Med., July 1, 2008; 178(1): 42 - 49.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Latzin, D. Hartl, N. Regamey, U. Frey, M. H. Schoeni, and C. Casaulta
Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis
Eur. Respir. J., January 1, 2008; 31(1): 36 - 42.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Giavina-Bianchi, E. Oliveira, and J. Kalil
Specific IgE against Recombinant Allergens in Allergic Bronchopulmonary Aspergillosis
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 967a - 967a.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Crameri and R. Kraemer
Specific IgE against Recombinant Allergens in Allergic Bronchopulmonary Aspergillosis
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 967b - 968.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. J. Accurso
Update in Cystic Fibrosis 2006
Am. J. Respir. Crit. Care Med., April 15, 2007; 175(8): 754 - 757.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society
  ATS 2008 State of the Art Course